Paclitaxel‐based chemotherapy for aggressive kaposiform hemangioendothelioma of the temporomastoid region: Case report and review of the literature

Kaposiform hemangioendothelioma (KHE) is a rare vascular tumor of infancy and childhood. This tumor results in poor prognosis, and therefore, development of a more effective treatment is needed.

[1]  S. Arbuckle,et al.  Successful Treatment of Kaposiform Hemangioendothelioma and Tufted Angioma With Vincristine , 2010, Journal of pediatric hematology/oncology.

[2]  Sheau-Fang Yang,et al.  Kaposiform Hemangioendothelioma Arising From the Maxillary Sinus: A Case Report , 2010, The Kaohsiung journal of medical sciences.

[3]  T. Valdez,et al.  Kaposiform hemangioendothelioma (with Kasabach Merritt syndrome) of the head and neck: case report and review of the literature. , 2009, International journal of pediatric otorhinolaryngology.

[4]  M. Sheridan-Pereira,et al.  Mediastinal and Neck Kaposiform Hemangioendothelioma: Report of Three Cases , 2009, Pediatric dermatology.

[5]  Y. Fernández,et al.  Kaposiform hemangioendothelioma. , 2009, European journal of internal medicine.

[6]  B. Cho,et al.  Intracranial kaposiform hemangioendothelioma: proposal of a new malignant variant. , 2009, Journal of neurosurgery. Pediatrics.

[7]  J. Blay,et al.  Phase II trial of weekly paclitaxel for unresectable angiosarcoma: the ANGIOTAX Study. , 2008, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[8]  X. Nie,et al.  Kaposiform hemangioendothelioma: Case report and literature review , 2007 .

[9]  S. Schmid,et al.  Kaposiform hemangioendothelioma arising in the ethmoid sinus of an 8‐year‐old girl with severe epistaxis , 2006, Head & neck.

[10]  M. Han,et al.  Kaposiform hemangioendothelioma arising from the internal auditory canal. , 2006, AJNR. American journal of neuroradiology.

[11]  P. Troncoso,et al.  Protracted remission of metastatic epithelioid angiosarcoma with weekly infusion of doxorubicin, paclitaxel, and cisplatin. , 2006, The Lancet. Oncology.

[12]  R. Sciot,et al.  Primary temporal bone angiosarcoma: a case report , 2005, Journal of Neuro-Oncology.

[13]  A. Folpe,et al.  Kaposiform Hemangioendothelioma: A Study of 33 Cases Emphasizing Its Pathologic, Immunophenotypic, and Biologic Uniqueness From Juvenile Hemangioma , 2004, The American journal of surgical pathology.

[14]  M. Bernstein,et al.  Phase 1 Study of Paclitaxel Administered Twice Weekly to Children With Refractory Solid Tumors: A Pediatric Oncology Group Study , 2003, Journal of pediatric hematology/oncology.

[15]  D. Hardisson,et al.  Kaposiform hemangioendothelioma of the external auditory canal in an adult , 2002, Head & neck.

[16]  J. Haller,et al.  A case of head and neck kaposiform hemangioendothelioma simulating a malignancy on imaging , 2001, Pediatric Radiology.

[17]  H. Friedman,et al.  Paclitaxel for the Treatment of Progressive or Recurrent Childhood Brain Tumors: A Pediatric Oncology Phase II Study , 2001, Journal of pediatric hematology/oncology.

[18]  G. Schwartz,et al.  Paclitaxel in the treatment of patients with angiosarcoma of the scalp or face , 1999, Cancer.

[19]  M. Relling,et al.  Phase I targeted systemic exposure study of paclitaxel in children with refractory acute leukemias. , 1999, Clinical cancer research : an official journal of the American Association for Cancer Research.

[20]  M. Relling,et al.  Phase I trial of paclitaxel in children with refractory solid tumors: a Pediatric Oncology Group Study. , 1993, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[21]  S. Weiss,et al.  Kaposiform Hemangioendothelioma of Infancy and Childhood: An Aggressive Neoplasm Associated with Kasabach-Merritt Syndrome and Lymphangiomatosis , 1993, The American journal of surgical pathology.